Interestingly, SERPINB9 expression is reduced in atherosclerotic lesions72, and the axis SERPINB9/granzyme B has been proposed to modulate inflammation and insulin resistance in coronary atherosclerosis68. This evidence concerns the gene GZMB and Insulin resistance.